Chlorthalidone Tablet
Product Images NDC 68382-971

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlorthalidone (NDC 68382-971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fe770c95 8c05 4749 A350 63266f3c6636 01

Chemical structure diagram of chlorthalidone, showing its molecular arrangement with labeled functional groups including hydroxyl, sulfonamide, and chlorine atoms.*

FDA Label Image

Fe770c95 8c05 4749 A350 63266f3c6636 02

Label for Chlorthalidone Tablets USP 25 mg in tablet form, containing 100 tablets. The label includes storage instructions, manufacturer information (Cadila Healthcare Ltd., India), and distributor details (Zydus Pharmaceuticals USA Inc.). It specifies Rx only and emphasizes keeping the container tightly closed and out of children's reach.*

FDA Label Image

Fe770c95 8c05 4749 A350 63266f3c6636 03

Chlorthalidone Tablets USP 50 mg oral tablets label by Zydus Pharmaceuticals USA Inc. The label indicates a package containing 100 tablets, prescription only. It includes storage instructions, dosage advisory, and manufacturer details stating production by Cadila Healthcare Ltd. in India with distribution by Zydus Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.